Skip to content

A Study on the Key Technologies and Clinical Application of Stasis-removing and Collateral-dredging Medicinal Moxibustion for Preventing and Treating Post-stroke Dysphagia Based on the Theory of "Preventive Treatment of Disease"

A Study on the Key Technologies and Clinical Application of Stasis-removing and Collateral-dredging Medicinal Moxibustion for Preventing and Treating Post-stroke Dysphagia Based on the Theory of "Preventive Treatment of Disease"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001571
Enrollment
Unknown
Registered
2025-08-19
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke dysphagia

Interventions

control group:Western medicine routine basic treatment + acupuncture
Medicinal moxibustion group:Western medicine routine basic treatment + acupuncture + medicinal moxibustion

Sponsors

The Second Affiliated Hospital of Anhui University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 85 Years

Inclusion criteria

Inclusion criteria: Those meeting the diagnostic criteria: TCM diagnostic criteria: formulated with reference to the diagnostic criteria for "apoplexy" in Diagnostic and Efficacy Evaluation Criteria for Apoplexy developed by the Encephalopathy Emergency Collaboration Group of the State Administration of Traditional Chinese Medicine in 1996. Western medicine diagnostic criteria: conforming to the diagnostic criteria for stroke in Diagnostic Points for Various Major Cerebrovascular Diseases in China 2019 and confirmed as cerebral hemorrhage or cerebral infarction by CT or MRI examination. Complicated with dysphagia manifested as water choking, dysarthria, abnormal pharyngeal reflex, cough after eating, etc. Aged 35–85 years; With a disease course of within 6 months; With stable vital signs, clear consciousness and ability to cooperate with the operation process; Voluntarily participating in this study and signing the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Cases of large-area cerebral infarction and severe cerebral hemorrhage; 2. Patients with a history of oropharyngeal or esophageal structural abnormalities or true bulbar palsy; 3. Those with a disease course of more than 6 months; 4. Patients with disturbance of consciousness; 5. Those with severe cognitive impairment; 6. Those with severe multiple organ failure; 7. Those who failed to complete the treatment course as per the trial plan.

Design outcomes

Primary

MeasureTime frame
Pulse oxygen saturation detection;Water Swallowing Test;Standardized Swallowing Assessment, SSA;Immune Function;Nutritional Indicators(Total Lymphocyte Count, Immunoglobulin G, Immunoglobulin A, Hemoglobin, Albumin, Serum Total Protein);

Secondary

MeasureTime frame
Incidence of Adverse Reactions;Clinical Symptoms and Signs of Patients;

Countries

China

Contacts

Public ContactSu Xingxing

The Second Affiliated Hospital of Anhui University of Chinese Medicine

1575534412@163.com15755234412

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026